Search
Filter Results
Displaying 641–650 of 851 results for “vision connection”
-
Jul 17, 2020
Research NewsA Phase 3 trial for the treatment is planned
-
May 15, 2020
Foundation NewsEnhancements include streamlined data entry, improved site navigation, better accessibility for low-vision users, and efficient integration with mobile technology.
-
May 5, 2020
Foundation Fighting Blindness Announces National Virtual VisionWalk Day
NewsThis new virtual event on June 6th will raise awareness and fund research leading to treatments and cures for blindness caused by retinal diseases.
-
Mar 30, 2020
10 Things to Know Before You Fall Victim to a Retinal Stem Cell Scam
Research NewsAn article by David Gamm, MD, PhD, a Foundation-funded researcher at the University of Wisconsin-Madison
-
Feb 27, 2020
Researchers Report Six-Month Results from Biogen-Sponsored XLRP Gene Therapy Clinical Trial
Research NewsVision improvements observed with medium and high doses
-
Simple Ways to Leave Your Legacy
Many people who don’t have the resources to make a significant gift during their lifetime choose to leave a meaningful gift in their will. By leaving a gift to the Foundation, you will provide vital support for the research that will soon find an end to vision loss. You can leave a legacy of sight.
-
Jan 9, 2020
Foundation Fighting Blindness Celebrates 15th Year of VisionWalk with New Branding
Foundation NewsThis signature fundraising event has raised more than $55 million for research leading to treatments and cures for blindness.
-
Nov 27, 2019
Foundation NewsKnown as Pro-EYS, the study will help researchers design clinical trials for potential therapies
-
Oct 29, 2019
Iveric Bio’s Therapy Slows Retinal Degeneration in Phase 2b Trial for Dry AMD
Research NewsZimura inhibits a complement protein known as C5, a component of the immune system that, when overactive, can cause retinal degeneration.
-
Jul 25, 2019
Allergan and Editas Begin Recruiting for CRISPR/Cas9 Clinical Trial for LCA10
Research NewsThe trial will be the first for a CRISPR/Cas9 therapy administered inside the human body.